medline.ch ORL Hals

	Integrative radiopathomics model for predicting progression-free survival in patients with nonmetastatic nasopharyngeal carcinoma. J Cancer Res Clin Oncol Hou J, Yi X, Li H, Lu Q, Lin H, Li J, Zeng B, Yu X. PMID: 39249584 [PubMed - indexed for MEDLINE]
	The serological diagnostic value of EBV-related IgA antibody panels for nasopharyngeal carcinoma: a diagnostic test accuracy meta-analysis. BMC Cancer Liu H, Lei L, Song S, Geng X, Lin K, Li N, Chen W, Peng J, Ren J. PMID: 39244576 [PubMed - indexed for MEDLINE]
	Xerostomia prediction in patients with nasopharyngeal carcinoma during radiotherapy using segmental dose distribution in dosiomics and radiomics models. Oral Oncol Zhang X, Zheng W, Huang S, Li H, Bi Z, Yang X. PMID: 39226775 [PubMed - indexed for MEDLINE]
	Effect analysis of 847 nasopharyngeal carcinoma cases treated with intensity modulated radiation: Experience and suggestions. Oral Oncol Yin WJ, Mao W, Yang F, Wang MY, Liu JQ, Chen DP, Zhou LP, Chen SD, Jiang XZ, Ou YM, Wu Z, Qi B. PMID: 39216209 [PubMed - indexed for MEDLINE]
	A systematic review of the predictive value of radiomics for nasopharyngeal carcinoma prognosis. Medicine (Baltimore) Deng Q, Hou Y, Zhang X, Zan H. PMID: 39213210 [PubMed - indexed for MEDLINE]
	A scoring system based on inflammatory and nutritional indicators to predict the long-term survival of patients with non-metastatic nasopharyngeal carcinoma. Sci Rep Fang WN, Wu HX, Wu ZP, Fei ZD, Zhao D, Chen F, Lin C, Ma LQ. PMID: 39215059 [PubMed - indexed for MEDLINE]
	Identifying biomarkers for nasopharyngeal carcinoma diagnosis and chemoradiotherapy response using serum endogenous small molecules profiling. J Pharm Biomed Anal Xu Z, Sun H, Wang Z, Li J, Gu J. PMID: 39208647 [PubMed - indexed for MEDLINE]
	Impact of Matrix Metalloproteinase-8 Polymorphisms on Nasopharyngeal Carcinoma Risk. Anticancer Res Chen CH, Chin YT, Hsu SW, Shih LC, Tien HC, Tsai CW, Wang YC, Liu YF, Bau DT, Chang WS. PMID: 39197904 [PubMed - indexed for MEDLINE]
	Multimodal treatment according to the NPC-GPOH trials in adult patients with nasopharyngeal cancer-Analysis based on a single-center experience. Cancer Rep (Hoboken) Leu M, Bohnenberger H, Guhlich M, Schirmer MA, Pilavakis Y, Wolff HA, Rieken S, Dröge LH. PMID: 39191673 [PubMed - indexed for MEDLINE]
	Development and validation of a practical score to predict 3-year distant metastatic free survival in nasopharyngeal carcinoma incorporating the number of lymph node regions. PLoS One Jaruthien T, Lertbutsayanukul C, Jittapiromsak N, Sriyook A, Kulalert P, Tantiyavarong P, Kitpanit S, Kannarunimit D, Chakkabat C, Prayongrat A. PMID: 39190649 [PubMed - indexed for MEDLINE]
	Development and application of a serious adverse events risk model for concurrent chemoradiotherapy in patients with nasopharyngeal carcinoma. Medicine (Baltimore) Li J, Liu Q, Qin H. PMID: 39183401 [PubMed - indexed for MEDLINE]
	Current state, challenges, and future perspective of adaptive radiotherapy: A narrative review of nasopharyngeal carcinoma. Oral Oncol Zhou X, Shao T, Jia H, Hou L, Tang X, Yu C, Zhou C, Zhou S, Yang H. PMID: 39182359 [PubMed - indexed for MEDLINE]
	Comparative dosimetric analysis of normal brain tissue in patients with Nasopharyngeal carcinoma at different stages after radiation therapy. Oral Oncol Du F, Shao K, Yang Y, Bai X, Hua Y, Shan G. PMID: 39178506 [PubMed - indexed for MEDLINE]
	Causes of missed MRI diagnosis of radiotherapy-induced temporal lobe injury in nasopharyngeal carcinoma. Zhong Nan Da Xue Xue Bao Yi Xue Ban Chen R, Zhao L, Yang F, Zhou G, Wang D, Zhao Q, Liao W. PMID: 39174883 [PubMed - indexed for MEDLINE]
	Challenges and innovations in managing a complex giant bilateral juvenile nasopharyngeal angiofibroma with intracranial extension. BMJ Case Rep Eugine R, Ps S, Bhardwaj A, Sahu MP. PMID: 39174044 [PubMed - indexed for MEDLINE]
	Single-cell resolution profiling of the immune microenvironment in primary and metastatic nasopharyngeal carcinoma. J Cancer Res Clin Oncol Liu Q, Xu J, Dai B, Guo D, Sun C, Du X. PMID: 39158776 [PubMed - indexed for MEDLINE]
	The role of microbiota in nasopharyngeal cancer: Where do we stand? Oral Oncol Ashique S, Houshyari M, Islam A, Pal R, Ghazanfar S, Taghizadeh-Hesary F. PMID: 39153457 [PubMed - indexed for MEDLINE]
	Tumor habitat-based MRI features assessing early response in locally advanced nasopharyngeal carcinoma. Oral Oncol Yuan J, Wu M, Qiu L, Xu W, Fei Y, Zhu Y, Shi K, Li Y, Luo J, Ding Z, Sun X, Zhou S. PMID: 39151333 [PubMed - indexed for MEDLINE]
	Peripheral hemoglobin to albumin ratio predicts prognosis in patients with nasopharyngeal carcinoma underwent concurrent chemoradiotherapy. BMC Cancer Zhang C, Wang SF, Zhang YL, Teng CX. PMID: 39148032 [PubMed - indexed for MEDLINE]
	Gemcitabine, capecitabine, and tislelizumab in recurrent/metastatic nasopharyngeal carcinoma following prior anti-PD-1 therapy failure: A retrospective study. Oral Oncol Yang R, Li R, Niu X, Zhao Y, Yan L, Tian S, Zhu Y, Qiu J, Wang X. PMID: 39142147 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 8250

Seite 1 von 413

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung